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Background & significance
Glioblastoma (GBM) remains prognostically dismal, with
only modest gains in mean survival time with chemo-
and radiotherapy motivating research into reversing its
characteristic local and systemic immunosuppression
with precision in this high-risk tissue. While whole-
repertoire amplification of the TCR repertoire allows
unprecedented depth regarding the potentiation of
anti-tumor responses, most studies utilize TCRseq for
monitoring reactivity to specific tumor antigens, or the
identities of particular TCRs as biomarkers. In this
study, we have utilized whole-repertoire analysis to
describe the relationship between intra-tumoral T cells
and peripheral circulation, and leverage mutual infor-
mation between gene expression and the behavior of
the T cell population to characterize glioma-reactive
states, driven by the gene expression of the principal
resident monocyte population, and perturbable by
immunological interventions.
Methods & results
From resected tumor tissue and peripheral lymphocytes
of low- and high-grade human glioma patients, TCRseq
libraries were generated using reverse transcription and
nested PCR (iRepertoire [1]) of the complementarity-
determining region 3 (CDR3) of the TCR-alpha and
TCR-beta chains, then sequenced on an Illumina MiSeq.
We developed a computational pipeline for mapping
TCR cassettes, in silico translation, and sequence error
correction from these libraries, enabling sensitive calcula-
tion of tumor-infiltrating lymphocyte (TIL) and periph-
eral TCR diversity (Shannon entropy) [2], as well as the
divergence (Jensen-Shannon divergence metric) between
the two T cell populations.
By integrating amino acid identity and V-J cassette com-
bination, we observed varying levels of divergence between
the TIL and peripheral lymphocytes of glioma patients,
and changes in this divergence over tumor progression in
a PDGF-driven murine model. Correlation of these prop-
erties with tumor tissue RNA profiling, by differential gene
expression and mutual-information gene ontology,
revealed an association between tumor growth and high
blood-brain TCR divergence - particularly in amino-acid
sequence, suggesting antigen-driven selection - while high
expression of inflammatory and certain immune pathway
markers computationally attributed to microglia [3] were
anti-correlated with divergence. Preliminary murine
experiments suggest that TCR divergence can be altered
by induction and blockade of cytokine-mediated activation
of these pathways.
Conclusion
The expression of a subset of microglia-associated genes
appears to describe micro-environmental states which
are strongly tied to the tumor-specificity of the intra-
tumoral TCR repertoire, complementary to the tumor-
centric classifications of TCGA. TCRseq-based profiling
not only promises to inform tailoring of local and systemic
immunotherapy to target the most relevant immunosup-
pressive mechanisms, but may also provide non-invasive
assessment of the intra-tumoral environment for refined
diagnosis and monitoring during clinical trials.
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